Nodular malignant melanoma and multiple cutaneous neoplasms under immunosuppression with azathioprine

Melanoma Research

Volumn 19, Issue 4, 2009, Pages 271-273

  Guenova, Emmanuella ^a,b   Lichte, Verena ^a   Hoetzenecker, Wolfram ^a   Woelbing, Florian ^a   Moehrle, Matthias ^a   Roecken, Martin ^a   Schaller, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Azathioprine; Immunosuppressive therapy; Malignant melanoma; Renal transplantation; Skin cancer

Indexed keywords

AZATHIOPRINE; PREDNISOLONE; TEMOZOLOMIDE;

AGED; ARM EDEMA; ARTICLE; AXILLARY LYMPH NODE; BASAL CELL CARCINOMA; BRAIN METASTASIS; CANCER MORTALITY; CASE REPORT; DYSPNEA; EXCISION; GRAFT RECIPIENT; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MAINTENANCE THERAPY; MALE; MELANOMA; MULTIPLE CANCER; PLEURA EFFUSION; PRIORITY JOURNAL; RISK REDUCTION; SCAPULA; SENTINEL LYMPH NODE BIOPSY; SKIN CANCER; SPLEEN; SQUAMOUS CELL CARCINOMA; SUBCUTANEOUS NODULE; SYSTEMIC DISEASE; TREATMENT DURATION; ULTRAVIOLET RADIATION;

AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; AZATHIOPRINE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DACARBAZINE; DRUG THERAPY, COMBINATION; EARLY DETECTION OF CANCER; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHATIC METASTASIS; MALE; MELANOMA; NEOPLASMS, MULTIPLE PRIMARY; SKIN NEOPLASMS; SPLENIC NEOPLASMS;

EID: 68949122579     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32831bc44a     Document Type: Article

References (19)

1. Moloney FJ, Keane S, O'Kelly P, Conlon PJ, Murphy GM. The impact of skin disease following renal transplantation on quality of life. BrJ Dermatol 2005; 153:574-578.
2. Cohen EB, Komorowski RA, Clowry LJ. Cutaneous complications in renal transplant recipients. Am J Clin Pathol 1987; 88:32-37.
3. Lugo-Janer G, Sanchez JL, Santiago-Delpin E. Prevalence and clinical spectrum of skin diseases in kidney transplant recipients. J Am Acad Dermatol 1991; 24:410-414.
4. Laing ME, Moloney FJ, Kay EW, Conlon P, Murphy GM. Malignant melanoma in transplant patients: review of five cases. Clin Exp Dermatol 2006; 31:662-664.
5. Le Mire L, Hollowood K, Gray D, Bordea C, Wojnarowska F. Melanomas in renal transplant recipients. Br J Dermatol 2006; 154:472-477.
6. Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM.
7. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154:498-504.
8. O'Donovan P, Perrett CM, Zhang X, Montaner B, Xu YZ, Harwood CA, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309:1871-1874.
9. Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, et al. Incidence of ocular melanoma in Australia from 1990 to 1998. Int J Cancer 2003; 105:117-122.
10. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4:905-913.
11. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. IntJ Cancer 1995; 60:183-189.
12. Galvao MM, Sotto MN, Kihara SM, Rivitti EA, Sabbaga E. Lymphocyte subsets and Langerhans cells in sun-protected and sun-exposed skin of immunosuppressed renal allograft recipients. J Am Acad Dermatol 1998; 38:38-44.
13. Thomson MA, Suggett NR, Nightingale PG, Milford DV, Baumann U, Kelly DA, et al. Skin surveillance of a U.K. paediatric transplant population. BrJ Dermatol 2007; 156:45-50.
14. Otley CC, Pittelkow MR. Skin cancer in liver transplant recipients. Liver Transpl 2000; 6:253-262.
15. Hodi FS, Granter S, Antin J. Withdrawal of immunosuppression contributing to the remission of malignant melanoma: a case report. Cancer Immun 2005; 5:7.
16. Hoxtell EO, Mandel JS, Murray SS, Schuman LM, Goltz RW. Incidence of skin carcinoma after renal transplantation. Arch Dermatol 1977; 113: 436-438.
17. Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005; 352:1317-1323.
18. Wimmer CD, Rentsch M, Crispin A, Illner WD, Arbogast H, Graeb C, et al. The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int 2007; 71:1271-1278.
19. Gupta AK, Cardella CJ, Haberman HF. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol 1986; 122:1288-1293.